Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3943592 | Gynecologic Oncology | 2007 | 6 Pages |
Abstract
Paclitaxel 175Â mg/m2, carboplatin (AUCÂ =Â 5) and pegylated liposomal doxorubicin 30Â mg/m2 are tolerable without supportive therapy. The usual dose intensity of paclitaxel/carboplatin was maintained by administering liposomal doxorubicin every other cycle.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Peter G. Rose, Benjamin E. Greer, Ira R. Horowitz, Maurie Markman, Nancy Fusco,